Thornberry Nancy — SEC insider filings

SEC reporting owner CIK 1797826. 21 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-01-12 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Schrodinger, Inc. (SDGR)Director8—2 legs · 19,800 sh · $693,00014
VERTEX PHARMACEUTICALS INC / MA (VRTX)Director5—1 leg · 1,000 sh · $547,8609
Denali Therapeutics Inc. (DNLI)Director8—2 legs · 11,439 sh · $261,92913

Insider filings — Thornberry Nancy

FiledFormIssuerReported transactionsSource
2026-11-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 1,000 @ $547.86EDGAR
2026-09-044Denali Therapeutics Inc. (DNLI)Sale (S): 10,824 @ $22.85 · Sale (S): 615 @ $23.74EDGAR
2026-06-234Schrodinger, Inc. (SDGR)Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0EDGAR
2026-06-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0EDGAR
2026-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 472 @ $0 · Disposition to issuer (D): 398 · Grant/award (A): 1,433 (derivative) @ $0 · Grant/award (A): 398 (derivative)EDGAR
2025-06-204Schrodinger, Inc. (SDGR)Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0EDGAR
2025-06-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0EDGAR
2025-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 398 @ $0 · Grant/award (A): 1,199 (derivative) @ $0EDGAR
2024-06-204Schrodinger, Inc. (SDGR)Grant/award (A): 5,000 @ $0 · Grant/award (A): 8,550 (derivative) @ $0EDGAR
2024-06-044Denali Therapeutics Inc. (DNLI)Grant/award (A): 5,967 @ $0 · Grant/award (A): 17,901 (derivative) @ $0EDGAR
2024-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 501 @ $0 · Grant/award (A): 1,571 (derivative) @ $0EDGAR
2023-12-064VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,136 @ $0EDGAR
2023-06-164Schrodinger, Inc. (SDGR)Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2023-06-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 4,216 @ $0 · Grant/award (A): 12,649 (derivative) @ $0EDGAR
2023-05-234Schrodinger, Inc. (SDGR)Option exercise (M): 14,850 @ $11.52 · Sale (S): 14,850 @ $35 · Option exercise (M): 14,850 (derivative) @ $0EDGAR
2022-08-124Schrodinger, Inc. (SDGR)Option exercise (M): 4,950 @ $11.52 · Sale (S): 4,950 @ $35 · Option exercise (M): 4,950 (derivative) @ $0EDGAR
2022-06-164Schrodinger, Inc. (SDGR)Grant/award (A): 14,907 (derivative) @ $0EDGAR
2022-06-064Denali Therapeutics Inc. (DNLI)Grant/award (A): 5,986 @ $0 · Grant/award (A): 17,959 (derivative) @ $0EDGAR
2022-01-114Denali Therapeutics Inc. (DNLI)Grant/award (A): 627 @ $0EDGAR
2021-06-214Schrodinger, Inc. (SDGR)Grant/award (A): 8,736 (derivative) @ $0EDGAR
2021-01-124Denali Therapeutics Inc. (DNLI)Grant/award (A): 7,535 (derivative) @ $0 · Grant/award (A): 2,511 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs